Ardent Health (NYSE:ARDT) Stock Price Target Raised at Stephens

Ardent Health (NYSE:ARDT) had its price objective hoisted by Stephens from $13.00 to $21.00 in a report published on Friday,Benzinga reports. They currently have an overweight rating on the stock.

A number of other equities research analysts have also recently commented on ARDT. Truist Financial raised their target price on shares of Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Monday, September 7th. Royal Bank Of Canada upped their price target on shares of Ardent Health from $13.00 to $18.00 and gave the stock an “outperform” rating in a research report on Friday. Leerink Partners reissued an “outperform” rating and issued a $14.00 price objective on shares of Ardent Health in a research note on Friday, September 18th. Finally, BMO Capital Markets began coverage on shares of Ardent Health in a research report on Tuesday, September 22nd. They set a “market perform” rating and a $11.00 price objective on the stock. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $13.54.

Ardent Health Stock Performance

ARDT traded up $1.32 during midday trading on Friday, reaching $17.23. The company had a trading volume of 3,465,561 shares, compared to its average volume of 486,889. The company has a quick ratio of 1.99, a current ratio of 2.10 and a debt-to-equity ratio of 0.61. The business has a 50-day moving average of $11.44 and a two-hundred day moving average of $10.10. The company has a market cap of $2.43 billion, a P/E ratio of 16.72, a P/E/G ratio of 3.32 and a beta of 0.58. Ardent Health has a 1 year low of $7.71 and a 1 year high of $17.67.

Ardent Health (NYSE:ARDT) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.23 by $0.08. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%. The firm had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.60 billion. As a group, equities research analysts predict that Ardent Health will post 0.96 earnings per share for the current fiscal year.

Institutional Trading of Ardent Health

Hedge funds have recently bought and sold shares of the stock. Allworth Financial LP bought a new position in shares of Ardent Health during the 2nd quarter valued at about $28,000. Integrated Wealth Concepts LLC bought a new stake in shares of Ardent Health in the second quarter worth about $57,000. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of Ardent Health in the third quarter worth about $61,000. Abel Hall LLC purchased a new stake in shares of Ardent Health in the first quarter worth about $87,000. Finally, Brighton Jones LLC purchased a new stake in shares of Ardent Health in the third quarter worth about $110,000.

Key Stories Impacting Ardent Health

Here are the key news stories impacting Ardent Health this week:

• Positive Sentiment: Ardent reported Q3 earnings of $0.31 per share, ahead of analyst estimates of roughly $0.23–$0.24, and revenue of $1.625 billion versus the $1.60 billion consensus. Recent coverage also highlighted a return to profitability and improved guidance. Zacks Q3 earnings report Profit and guidance coverage
• Positive Sentiment: Stephens raised its price target to $21 from $13 and maintained an Overweight rating, implying further potential upside from the quoted $17.23 share price. Stephens ratings
• Positive Sentiment: RBC lifted its target to $18 from $13 and reiterated an Outperform rating, signaling a more positive view after the results. RBC ratings
• Neutral Sentiment: The strong rally has brought the stock close to its 12-month high, and a recent analysis questioned whether shares may already be above fair value. That could limit further gains if investors have priced in the earnings beat and raised outlook. Valuation analysis
• Negative Sentiment: Despite beating estimates, quarterly EPS was below the $0.52 reported a year earlier, pointing to year-over-year earnings pressure. Zacks earnings comparison

About Ardent Health

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.